News

Science has something exploratory about it, says Norbert Hübner. You never know exactly where you are heading. Despite this, cartographic works are the focus of his interest: the researcher creates atlases of the human heart. And amongst other things, he uses them to understand heart conditions better.

Dr. Eleonora Adami is a postdoctoral research fellow at the Max Delbrück Center. The molecular biologist and geneticist studies heart failure by applying single-cell genomics approaches in the Hübner lab.

BRCA1/2-mutated tumor cells often survive treatment, whether it’s chemo- or radiotherapy, because they can repair therapy-induced DNA damage. A team led by Claus Scheidereit of the Max Delbrück Center has now reported in The EMBO Journal how blocking the TSG101 protein hinders these tumor cells from carrying out repair processes.

At ECRC, Theda Bartolomaeus investigates how the microbes that colonize the human body affect our lives. In our "Lunch Break" video series, the PhD student reveals how she got into biology – and why sports are so important to her.

Christian Stadelmann has been fascinated by CRISPR/Cas9 gene editing since he was an undergrad. Now, the PhD student is investigating the possibility of applying it to treat hereditary muscular dystrophy in Professor Simone Spuler's research group at the ECRC.

EMBO fellow Ilan Theurillat investigates how the most lethal subtype of breast cancer develops. He is driven by many unanswered questions such as: Why do fibroblasts wrap themselves around the triple negative tumor like a shield? Can such a tumor form from a single cancer cell?

Moving to Germany and starting a new job at the MDC in the middle of the first lockdown was not easy. It took months before Dr. Giovanna Diletta Ielacqua could finally meet her colleagues in person. In "LUNCH BREAK", the MRI expert answers our questions.

Science and art have a lot in common, at least when you look at it from Anita Waltho's perspective. In the second episode of “LUNCH BREAK“, she talks cellular trash, creativity in science and Berlin-Brandenburg's lakes.

Ian Erik Stewart doesn't like to completely give up work in his free time. Together with other scientists, he founded "EDGE" - an organisation dedicated to make neuroscience understandable through art. He reveals more in our new "LUNCH BREAK" video series.

Targeted treatment of basal-like breast cancer could be facilitated by YAP inhibitors in the future. As reported by an MDC team headed by Walter Birchmeier in the scientific journal "Cancer Research", this type of cancer requires the support of the YAP protein to stimulate the growth of cancer stem cells.